Evaluation of the Express Plus Range

NAActive, not recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 14, 2021

Primary Completion Date

October 31, 2025

Study Completion Date

April 30, 2026

Conditions
PhenylketonuriasPKUHomocystinuriaMaple Syrup Urine DiseaseHereditary TyrosinemiaGlutaric Acidemia I
Interventions
DIETARY_SUPPLEMENT

PKU express plus

PKU express plus is a powdered protein substitute for the dietary management of PKU. It is formulated in a variety of flavours to provide a convenient, low volume, lower calorie, pre-measured protein substitute, containing a full micronutrient profile.

Trial Locations (6)

BT12 6BA

Royal Belfast Hospital for Sick Children, Belfast

B15 2TG

Birmingham Women's and Children's Hospital, Birmingham

BS2 8BJ

Bristol Royal Hospital for Children, Bristol

G12 0XH

Greater Glasgow and Clyde NHS Foundation Trust, Glasgow

WC1N 3JH

Great Ormond Street Hospital for Children, London

NG7 2UH

Nottingham Children's Hospital, Nottingham

All Listed Sponsors
lead

Vitaflo International, Ltd

INDUSTRY